ENZO BIOCHEM INC - 294100102
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2025
· Q4 2024
Value (USD)
Total reported value ($000)
$2.357M
QoQ value delta ($000)
-$2.418M
(-50.64%)
Implied price effect (QoQ)
-48.35%
Shares
Total shares
6,400,361
QoQ shares delta
-297,382
(-4.44%)
Total shares held by funds (by quarter)
Top holders (Q1 2025)
Top 25 only
Full list
Early Q2 2025 data: only 6 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 770 | 2,082,229 | 0.0% |
| VANGUARD GROUP INC | 687 | 1,859,002 | 0.0% |
| BlackRock, Inc. | 354 | 957,775 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 159 | 431,042 | 0.0% |
| CITADEL ADVISORS LLC | 78 | 210,877 | 0.0% |
| STATE STREET CORP | 62 | 168,881 | 0.0% |
| DIMENSIONAL FUND ADVISORS LP | 51 | 138,126 | 0.0% |
| Squarepoint Ops LLC | 47 | 127,440 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28 | 77,200 | 0.0% |
| NORTHERN TRUST CORP | 24 | 67,204 | 0.0% |
| MORGAN STANLEY | 24 | 67,342 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22 | 60,041 | 0.0% |
| LAZARD ASSET MANAGEMENT LLC | 18 | 50,453 | 0.0% |
| UBS Group AG | 16 | 45,713 | 0.0% |
| XTX Topco Ltd | 7 | 21,193 | 0.0% |
| RAYMOND JAMES FINANCIAL INC | 6 | 17,016 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 10,026 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 1 | 3,962 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 1,915 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 793 | 0.0% |
| FMR LLC | 0 | 429 | 0.0% |
| PNC FINANCIAL SERVICES GROUP, INC. | 0 | 700 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 1,000 | 0.0% |
| SIMPLEX TRADING, LLC | 0 | 2 | 0.0% |